Prix Galien Canada 2009 Innovative Product Award Given To Pfizer Canada For Champix Efficacy
Date: 18th November 2009
According to a latest revelation, the Prix Galien Canada 2009 Innovative Product Award was given to Pfizer Canada as recognition of the effectiveness of the prescription-based anti-smoking drug champix, which is especially manufactured to target the addiction of nicotine in adults. Further sources make it apparent that the award was conferred on Pfizer Incl at an especially organized celebration ceremony in Ottawa last night. This award was given to Pfizer Incl. on the basis that its product champix because of its greater clinical efficiency, innovation and benefits and because it played the most significant role in improving Canadian patient care.
The decision to provide the award to Pfizer Canada was made by eight specialists involved in the area of pharmaceutical and Canadian research. Dr. Jacques Gagné, the President of Prix Galien Canada stated that the judges were extremely happy to present the Prix Galien Innovative Product Award to Champix. Altogether, he made it apparent that the jury regards Champix as a pioneering product.
The Prix Galien award is recognized as the most prominent award in the sphere of Canadian pharmaceutical innovation and research. This award acknowledges the achievements as well as efforts of pharmaceutical development and research and is also known as the Nobel prize of pharmaceutical research.
Source: http://www.newswire.ca/ |
